as on October 29, 2025 at 11:40 pm IST
Day's Low
Day's High
2.50%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
53.54%
Downside
0.88%
Upside
Check Roivant Sciences Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$12.8B
EPS (TTM)
-0.57
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
1.88
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-1.1B
Revenue (TTM)
23.2M
Profit Margin
0.00%
Return On Equity TTM
-18.15%
Track how Roivant Sciences Ltd. P/E has moved over time to understand its valuation trends.
Roivant Sciences Ltd. in the last 5 years
Lowest (-20.32x)
December 31, 2024
Today (1.88x)
October 29, 2025
Industry (8.36x)
October 29, 2025
Highest (-2.45x)
September 30, 2022
Today’s Price to Earnings Ratio: 1.88x
Compare market cap, revenue, PE, and other key metrics of Roivant Sciences Ltd. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $12.8B | NA | 1.88 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
The Roivant Sciences Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Roivant Sciences Ltd. investment value today
Current value as on today
₹1,67,324
Returns
₹67,324
(+67.32%)
Returns from Roivant Sciences Ltd. Stock
₹62,263 (+62.26%)
Dollar Returns*
₹5,061 (+5.06%)
Based on 17 analysts
88.24%
Buy
11.76%
Hold
0.00%
Sell
Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Roivant Sciences Ltd.. Average target price of $20.05
Get share price movements and forecasts by analysts on Roivant Sciences Ltd..
What analysts predicted
6.28%UPSIDE
Target Price
$20.05
Current Price
$18.79
Analyzed by
17 Analysts
Target
$20.05
Roivant Sciences Ltd. target price $20.05, a slight upside of 6.28% compared to current price of $18.79. According to 17 analysts rating.
Search interest for Roivant Sciences Ltd. Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 September
Wed, 09:30 PM
-Roivant Sciences stock rises 11% after positive Phase 3 trial results for brepocitinib in treating dermatomyositis.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, ROIV has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, ROIV stock has moved up by 21.9%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.2% return, outperforming this stock by 8.2%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 169.38M → -223.35M (in $), with an average decrease of 115.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 9.01M → 2.17M (in $), with an average decrease of 43.7% per quarter
| Organisation | Roivant Sciences Ltd. |
| Headquarters | 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB |
| Industry | Financial |
| CEO | Mr. Matthew Gline |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director |
Ms. Jennifer Humes | Chief Accounting Officer |
Dr. Frank M. Torti M.B.A., M.D. | President & Vant Chair |
Ms. Kelly Graff | Head of People |
Mr. Matthew Gline | CEO & Director |
Mr. Richard Pulik | Chief Financial Officer |
Dr. Huafeng Xu Ph.D. | Chief Technology Officer |
Mr. Ian Rosenblum | Chief Information Officer |
Mr. Josh Chen J.D. | General Counsel |
Dr. Eric Venker M.D., Pharm.D. | President & CEO of Immunovant |
Roivant Sciences Ltd. share price today is $18.79 as on . Roivant Sciences Ltd. share today touched a day high of $18.91 and a low of $18.32.
Roivant Sciences Ltd. share touched a 52 week high of $18.96 on and a 52 week low of $8.73 on . Roivant Sciences Ltd. stock price today i.e. is trending at $18.79,which is 0.87% down from its 52 week high and 115.23% up from its 52 week low.
Roivant Sciences Ltd. market capitalisation is $0.01T as on .
Indian investors can start investing in Roivant Sciences Ltd. (ROIV) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Roivant Sciences Ltd. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Roivant Sciences Ltd. share’s latest price of $18.79 as on October 29, 2025 at 11:40 pm IST, you will get 0.5322 shares of Roivant Sciences Ltd.. Learn more about
fractional shares .